Six Convergent Photoreceptor Pathways: A Computational-Mechanistic Framework for Vision Enhancement in Presbyopia and Early Retinal Degeneration
Fuente:
Zenodo
Guardado en:
| Autor principal: | |
|---|---|
| Formato: | Recurso digital |
| Publicado: |
Zenodo
2025
|
| Materias: | |
| Acceso en línea: | |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| _version_ | 1866902017472987136 |
|---|---|
| author | Al-Zawahreh, Mohamad |
| author_facet | Al-Zawahreh, Mohamad |
| contents | <p>Antimony sulfide (Sb₂S₃) kohl (ithmid/surma) has been prescribed in Islamic medical tradition for over 1,400 years for vision enhancement. Using AlphaFold3 structure prediction, molecular docking, and computational biology, we identified six independent photoreceptor mechanisms with predicted combined amplification of 3.71-4.63×, translating to 37-63% vision improvement in scotopic (dim-light) conditions.</p> <p> </p> <p> </p> <p> Mechanisms include: (1) TRPV1 infrared sensitization (23-47% dark current amplification), (2) cGMP-gated ion channel amplification (18-34%), (3) mitochondrial ATP enhancement (12-31%), (4) RPE retinoid recycling acceleration (8-12 min dark adaptation improvement), (5) hormetic antioxidant upregulation (34-52% lipofuscin reduction), and (6) quantum spin-orbit stabilization (8-12%, speculative).</p> <p> </p> <p> </p> <p> Validation strategy includes Phase 0 ex vivo studies, Phase I animal/human safety trials, and Phase II efficacy studies. This demonstrates that rigorous computational analysis of historical medical prescriptions reveals coherent, testable mechanisms amenable to modern experimental validation.</p> |
| format | Recurso digital |
| id | zenodo_https___doi_org_10_5281_zenodo_17767485 |
| institution | Zenodo |
| language | |
| publishDate | 2025 |
| publisher | Zenodo |
| record_format | zenodo |
| spellingShingle | Six Convergent Photoreceptor Pathways: A Computational-Mechanistic Framework for Vision Enhancement in Presbyopia and Early Retinal Degeneration Al-Zawahreh, Mohamad ithmid antimony sulfide quantum molecular targeting photoreceptor vision enhancement presbyopia <p>Antimony sulfide (Sb₂S₃) kohl (ithmid/surma) has been prescribed in Islamic medical tradition for over 1,400 years for vision enhancement. Using AlphaFold3 structure prediction, molecular docking, and computational biology, we identified six independent photoreceptor mechanisms with predicted combined amplification of 3.71-4.63×, translating to 37-63% vision improvement in scotopic (dim-light) conditions.</p> <p> </p> <p> </p> <p> Mechanisms include: (1) TRPV1 infrared sensitization (23-47% dark current amplification), (2) cGMP-gated ion channel amplification (18-34%), (3) mitochondrial ATP enhancement (12-31%), (4) RPE retinoid recycling acceleration (8-12 min dark adaptation improvement), (5) hormetic antioxidant upregulation (34-52% lipofuscin reduction), and (6) quantum spin-orbit stabilization (8-12%, speculative).</p> <p> </p> <p> </p> <p> Validation strategy includes Phase 0 ex vivo studies, Phase I animal/human safety trials, and Phase II efficacy studies. This demonstrates that rigorous computational analysis of historical medical prescriptions reveals coherent, testable mechanisms amenable to modern experimental validation.</p> |
| title | Six Convergent Photoreceptor Pathways: A Computational-Mechanistic Framework for Vision Enhancement in Presbyopia and Early Retinal Degeneration |
| topic | ithmid antimony sulfide quantum molecular targeting photoreceptor vision enhancement presbyopia |
| url | https://doi.org/10.5281/zenodo.17767485 |